

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.65913763 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.58942494 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.30404433 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.30404433 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.30404433 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 4.30404433 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.30404433 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 4.30404433 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.18536362 |
| 10 | response to peptidoglycan (GO:0032494) | 4.04523611 |
| 11 | macrophage activation involved in immune response (GO:0002281) | 3.84894376 |
| 12 | negative regulation of cell killing (GO:0031342) | 3.81297031 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.81297031 |
| 14 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.70310041 |
| 15 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.67052769 |
| 16 | mannose metabolic process (GO:0006013) | 3.65032365 |
| 17 | response to muramyl dipeptide (GO:0032495) | 3.58910698 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.50865952 |
| 19 | detection of molecule of bacterial origin (GO:0032490) | 3.44353409 |
| 20 | regulation of gamma-delta T cell activation (GO:0046643) | 3.41348992 |
| 21 | detection of other organism (GO:0098543) | 3.36990444 |
| 22 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.27259468 |
| 23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.26877042 |
| 24 | regulation of chromatin binding (GO:0035561) | 3.26639174 |
| 25 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.23614259 |
| 26 | detection of bacterium (GO:0016045) | 3.21252415 |
| 27 | histone H3-K36 demethylation (GO:0070544) | 3.18976543 |
| 28 | cellular extravasation (GO:0045123) | 3.18489201 |
| 29 | detection of external biotic stimulus (GO:0098581) | 3.15734242 |
| 30 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 3.15620236 |
| 31 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.09143019 |
| 32 | germinal center formation (GO:0002467) | 3.06282743 |
| 33 | regulation of ARF GTPase activity (GO:0032312) | 3.05563127 |
| 34 | positive thymic T cell selection (GO:0045059) | 3.04451311 |
| 35 | B cell receptor signaling pathway (GO:0050853) | 2.96794749 |
| 36 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.94878583 |
| 37 | regulation of leukocyte degranulation (GO:0043300) | 2.94698538 |
| 38 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.90396699 |
| 39 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.89790048 |
| 40 | response to laminar fluid shear stress (GO:0034616) | 2.87965799 |
| 41 | regulation of mast cell degranulation (GO:0043304) | 2.87708977 |
| 42 | leukocyte aggregation (GO:0070486) | 2.86850788 |
| 43 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.85001180 |
| 44 | negative regulation of interleukin-12 production (GO:0032695) | 2.84374126 |
| 45 | NIK/NF-kappaB signaling (GO:0038061) | 2.83012934 |
| 46 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.82234925 |
| 47 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.81607918 |
| 48 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.81083358 |
| 49 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.79389877 |
| 50 | modulation by symbiont of host cellular process (GO:0044068) | 2.79038120 |
| 51 | detection of biotic stimulus (GO:0009595) | 2.77637152 |
| 52 | modulation by virus of host process (GO:0019054) | 2.77134369 |
| 53 | thymic T cell selection (GO:0045061) | 2.77009345 |
| 54 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.76901960 |
| 55 | response to host immune response (GO:0052572) | 2.76901960 |
| 56 | regulation of histone H3-K27 methylation (GO:0061085) | 2.75328203 |
| 57 | adenosine receptor signaling pathway (GO:0001973) | 2.75000781 |
| 58 | negative regulation of granulocyte differentiation (GO:0030853) | 2.74229465 |
| 59 | response to host (GO:0075136) | 2.72746515 |
| 60 | response to host defenses (GO:0052200) | 2.72746515 |
| 61 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.72746515 |
| 62 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.72127986 |
| 63 | neutrophil activation involved in immune response (GO:0002283) | 2.69491039 |
| 64 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.68227910 |
| 65 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.67230531 |
| 66 | cellular response to virus (GO:0098586) | 2.66436367 |
| 67 | myeloid cell activation involved in immune response (GO:0002275) | 2.66218017 |
| 68 | positive regulation of histone deacetylation (GO:0031065) | 2.63897766 |
| 69 | response to type I interferon (GO:0034340) | 2.60856423 |
| 70 | chromosome condensation (GO:0030261) | 2.59956649 |
| 71 | negative regulation of viral release from host cell (GO:1902187) | 2.59556518 |
| 72 | chromatin silencing (GO:0006342) | 2.57901287 |
| 73 | cellular response to type I interferon (GO:0071357) | 2.55915393 |
| 74 | type I interferon signaling pathway (GO:0060337) | 2.55915393 |
| 75 | embryonic process involved in female pregnancy (GO:0060136) | 2.55620434 |
| 76 | negative regulation of interleukin-8 production (GO:0032717) | 2.55579167 |
| 77 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.54238877 |
| 78 | apoptotic process involved in morphogenesis (GO:0060561) | 2.53161743 |
| 79 | negative regulation of histone methylation (GO:0031061) | 2.52256106 |
| 80 | positive regulation of interferon-alpha production (GO:0032727) | 2.52151896 |
| 81 | respiratory burst (GO:0045730) | 2.51631290 |
| 82 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.49989829 |
| 83 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.49276974 |
| 84 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.47562531 |
| 85 | protein localization to endosome (GO:0036010) | 2.46213705 |
| 86 | T cell selection (GO:0045058) | 2.45397603 |
| 87 | macrophage activation (GO:0042116) | 2.43172781 |
| 88 | histone lysine demethylation (GO:0070076) | 2.42102284 |
| 89 | immunoglobulin mediated immune response (GO:0016064) | 2.40065056 |
| 90 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.38803640 |
| 91 | positive regulation of myotube differentiation (GO:0010831) | 2.36849032 |
| 92 | positive T cell selection (GO:0043368) | 2.36426213 |
| 93 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.35886216 |
| 94 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.35733583 |
| 95 | regulation of necroptotic process (GO:0060544) | 2.35341937 |
| 96 | histone demethylation (GO:0016577) | 2.35275658 |
| 97 | pinocytosis (GO:0006907) | 2.35179792 |
| 98 | negative regulation of gene expression, epigenetic (GO:0045814) | 2.34556189 |
| 99 | histone H4 deacetylation (GO:0070933) | 2.34327797 |
| 100 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.34236082 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.91671790 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 3.37339630 |
| 3 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.84308586 |
| 4 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.73762335 |
| 5 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.66020450 |
| 6 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.60595817 |
| 7 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.55131600 |
| 8 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.54835635 |
| 9 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.51850416 |
| 10 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.43389681 |
| 11 | MAF_26560356_Chip-Seq_TH1_Human | 2.33026750 |
| 12 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.28627768 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.26029561 |
| 14 | MAF_26560356_Chip-Seq_TH2_Human | 2.09732736 |
| 15 | UTX_26944678_Chip-Seq_JUKART_Human | 2.03826637 |
| 16 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 2.00964198 |
| 17 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.00579366 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.98531041 |
| 19 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.98179552 |
| 20 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.95236722 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.93805996 |
| 22 | P68_20966046_ChIP-Seq_HELA_Human | 1.92776255 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.90813523 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89114894 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.84932757 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.73041285 |
| 27 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.69103346 |
| 28 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.68766435 |
| 29 | KDM2B_26808549_Chip-Seq_K562_Human | 1.68293751 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.66613116 |
| 31 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.62913444 |
| 32 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.62896097 |
| 33 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.61596557 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.61365039 |
| 35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.54142553 |
| 36 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53891281 |
| 37 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.53039098 |
| 38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.52808139 |
| 39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.52088353 |
| 40 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.51716038 |
| 41 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.50644214 |
| 42 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.47193232 |
| 43 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.45191115 |
| 44 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.43942399 |
| 45 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.42326062 |
| 46 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.41993916 |
| 47 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.41262198 |
| 48 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.37786628 |
| 49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37703050 |
| 50 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.37171865 |
| 51 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.35057133 |
| 52 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33456891 |
| 53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.32399961 |
| 54 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.30836955 |
| 55 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.30427127 |
| 56 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.29839724 |
| 57 | GATA1_19941826_ChIP-Seq_K562_Human | 1.27464327 |
| 58 | MYB_26560356_Chip-Seq_TH1_Human | 1.26242895 |
| 59 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.25673639 |
| 60 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.25228321 |
| 61 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.23974573 |
| 62 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.23119846 |
| 63 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.22748194 |
| 64 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.21816006 |
| 65 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.21696223 |
| 66 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.21283113 |
| 67 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21027921 |
| 68 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.20512902 |
| 69 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.20357353 |
| 70 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.19658521 |
| 71 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.19636943 |
| 72 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.19628770 |
| 73 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.19164439 |
| 74 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18745494 |
| 75 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18265283 |
| 76 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.17678803 |
| 77 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17490451 |
| 78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.16514162 |
| 79 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.16211485 |
| 80 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.14545524 |
| 81 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.13607566 |
| 82 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13461596 |
| 83 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.12503638 |
| 84 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.12158054 |
| 85 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11200609 |
| 86 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10951711 |
| 87 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.10780560 |
| 88 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.09517453 |
| 89 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09061798 |
| 90 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.08741982 |
| 91 | ATF3_27146783_Chip-Seq_COLON_Human | 1.08392006 |
| 92 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.07022024 |
| 93 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05054632 |
| 94 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.04931151 |
| 95 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.04758686 |
| 96 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.03836780 |
| 97 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.02772802 |
| 98 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.02672745 |
| 99 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.01437822 |
| 100 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.01250423 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.74907443 |
| 2 | MP0003436_decreased_susceptibility_to | 3.33620671 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.18796164 |
| 4 | MP0005451_abnormal_body_composition | 2.95022487 |
| 5 | MP0009278_abnormal_bone_marrow | 2.92650535 |
| 6 | MP0005076_abnormal_cell_differentiation | 2.73743153 |
| 7 | MP0003172_abnormal_lysosome_physiology | 2.37733100 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.25504689 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.20979836 |
| 10 | MP0000685_abnormal_immune_system | 2.19376921 |
| 11 | MP0002419_abnormal_innate_immunity | 2.11383048 |
| 12 | MP0004381_abnormal_hair_follicle | 2.04432103 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.01134021 |
| 14 | MP0008260_abnormal_autophagy | 2.00614061 |
| 15 | MP0005409_darkened_coat_color | 1.98969365 |
| 16 | MP0003763_abnormal_thymus_physiology | 1.97918838 |
| 17 | MP0005025_abnormal_response_to | 1.95045030 |
| 18 | MP0001800_abnormal_humoral_immune | 1.92639205 |
| 19 | MP0005000_abnormal_immune_tolerance | 1.89980608 |
| 20 | MP0004947_skin_inflammation | 1.88429546 |
| 21 | MP0003724_increased_susceptibility_to | 1.88297979 |
| 22 | MP0003453_abnormal_keratinocyte_physiol | 1.86438878 |
| 23 | MP0003091_abnormal_cell_migration | 1.79836379 |
| 24 | MP0005387_immune_system_phenotype | 1.79566214 |
| 25 | MP0001790_abnormal_immune_system | 1.79566214 |
| 26 | MP0002396_abnormal_hematopoietic_system | 1.78359055 |
| 27 | MP0002723_abnormal_immune_serum | 1.77573265 |
| 28 | MP0002452_abnormal_antigen_presenting | 1.76017398 |
| 29 | MP0005410_abnormal_fertilization | 1.75424200 |
| 30 | MP0001348_abnormal_lacrimal_gland | 1.74815820 |
| 31 | MP0009840_abnormal_foam_cell | 1.72420950 |
| 32 | MP0002420_abnormal_adaptive_immunity | 1.69570220 |
| 33 | MP0001819_abnormal_immune_cell | 1.68374868 |
| 34 | MP0002398_abnormal_bone_marrow | 1.65347670 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 1.64677153 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.56756801 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.56756801 |
| 38 | MP0004808_abnormal_hematopoietic_stem | 1.56092263 |
| 39 | MP0005083_abnormal_biliary_tract | 1.50415315 |
| 40 | MP0002405_respiratory_system_inflammati | 1.47651406 |
| 41 | MP0005671_abnormal_response_to | 1.46602843 |
| 42 | MP0000716_abnormal_immune_system | 1.43263960 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.42071672 |
| 44 | MP0000703_abnormal_thymus_morphology | 1.39403224 |
| 45 | MP0001849_ear_inflammation | 1.37677678 |
| 46 | MP0002722_abnormal_immune_system | 1.37599309 |
| 47 | MP0005310_abnormal_salivary_gland | 1.37538943 |
| 48 | MP0000858_altered_metastatic_potential | 1.37446541 |
| 49 | MP0009785_altered_susceptibility_to | 1.37142311 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.34520276 |
| 51 | MP0004510_myositis | 1.33443094 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.29736804 |
| 53 | MP0002429_abnormal_blood_cell | 1.29501569 |
| 54 | MP0003828_pulmonary_edema | 1.27651358 |
| 55 | MP0001873_stomach_inflammation | 1.24914845 |
| 56 | MP0000689_abnormal_spleen_morphology | 1.23737448 |
| 57 | MP0010155_abnormal_intestine_physiology | 1.22591146 |
| 58 | MP0004185_abnormal_adipocyte_glucose | 1.21645519 |
| 59 | MP0002132_abnormal_respiratory_system | 1.16819769 |
| 60 | MP0005464_abnormal_platelet_physiology | 1.16494672 |
| 61 | MP0006082_CNS_inflammation | 1.13893069 |
| 62 | MP0003566_abnormal_cell_adhesion | 1.10994109 |
| 63 | MP0004858_abnormal_nervous_system | 1.09865478 |
| 64 | MP0002148_abnormal_hypersensitivity_rea | 1.09139359 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.08582177 |
| 66 | MP0001845_abnormal_inflammatory_respons | 1.04869903 |
| 67 | MP0000015_abnormal_ear_pigmentation | 1.04619563 |
| 68 | MP0004233_abnormal_muscle_weight | 1.02208710 |
| 69 | MP0003448_altered_tumor_morphology | 1.01857768 |
| 70 | MP0000490_abnormal_crypts_of | 1.01607604 |
| 71 | MP0003111_abnormal_nucleus_morphology | 1.01159303 |
| 72 | MP0005377_hearing/vestibular/ear_phenot | 1.00921545 |
| 73 | MP0003878_abnormal_ear_physiology | 1.00921545 |
| 74 | MP0000003_abnormal_adipose_tissue | 1.00742216 |
| 75 | MP0005375_adipose_tissue_phenotype | 0.99677765 |
| 76 | MP0000678_abnormal_parathyroid_gland | 0.99143251 |
| 77 | MP0005666_abnormal_adipose_tissue | 0.99040647 |
| 78 | MP0005174_abnormal_tail_pigmentation | 0.98305493 |
| 79 | MP0008469_abnormal_protein_level | 0.93254348 |
| 80 | MP0004130_abnormal_muscle_cell | 0.86942994 |
| 81 | MP0002249_abnormal_larynx_morphology | 0.85956141 |
| 82 | MP0005171_absent_coat_pigmentation | 0.84908817 |
| 83 | MP0005621_abnormal_cell_physiology | 0.83025172 |
| 84 | MP0009931_abnormal_skin_appearance | 0.82638475 |
| 85 | MP0001986_abnormal_taste_sensitivity | 0.82069545 |
| 86 | MP0002166_altered_tumor_susceptibility | 0.81580530 |
| 87 | MP0005423_abnormal_somatic_nervous | 0.80246428 |
| 88 | MP0002933_joint_inflammation | 0.79125988 |
| 89 | MP0010307_abnormal_tumor_latency | 0.78950935 |
| 90 | MP0004264_abnormal_extraembryonic_tissu | 0.78546438 |
| 91 | MP0002254_reproductive_system_inflammat | 0.77182464 |
| 92 | MP0000750_abnormal_muscle_regeneration | 0.74788826 |
| 93 | MP0003183_abnormal_peptide_metabolism | 0.74640576 |
| 94 | MP0003329_amyloid_beta_deposits | 0.74026825 |
| 95 | MP0000313_abnormal_cell_death | 0.73305179 |
| 96 | MP0003077_abnormal_cell_cycle | 0.73281925 |
| 97 | MP0002019_abnormal_tumor_incidence | 0.72092261 |
| 98 | MP0002089_abnormal_postnatal_growth/wei | 0.70357380 |
| 99 | MP0000604_amyloidosis | 0.69582389 |
| 100 | MP0008057_abnormal_DNA_replication | 0.68678487 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.02654125 |
| 2 | Thin bony cortex (HP:0002753) | 3.58892958 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 3.40247795 |
| 4 | Recurrent abscess formation (HP:0002722) | 3.40170243 |
| 5 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.34581596 |
| 6 | Abnormality of macrophages (HP:0004311) | 3.29701655 |
| 7 | Abnormality of the fingertips (HP:0001211) | 3.25468090 |
| 8 | Hemorrhage of the eye (HP:0011885) | 3.09440765 |
| 9 | Cellulitis (HP:0100658) | 3.04643279 |
| 10 | Gastrointestinal infarctions (HP:0005244) | 2.95325233 |
| 11 | Colitis (HP:0002583) | 2.86843872 |
| 12 | Ulnar bowing (HP:0003031) | 2.85093353 |
| 13 | Gingivitis (HP:0000230) | 2.76872142 |
| 14 | Increased IgE level (HP:0003212) | 2.59333067 |
| 15 | Myositis (HP:0100614) | 2.56954447 |
| 16 | Recurrent fungal infections (HP:0002841) | 2.54627626 |
| 17 | Orchitis (HP:0100796) | 2.44088805 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 2.39198856 |
| 19 | Obstructive lung disease (HP:0006536) | 2.39198856 |
| 20 | Mediastinal lymphadenopathy (HP:0100721) | 2.37814312 |
| 21 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.36839333 |
| 22 | Intestinal fistula (HP:0100819) | 2.35952734 |
| 23 | Recurrent skin infections (HP:0001581) | 2.35105900 |
| 24 | Gastrointestinal inflammation (HP:0004386) | 2.34545073 |
| 25 | Broad face (HP:0000283) | 2.33569518 |
| 26 | Meningitis (HP:0001287) | 2.32589846 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 2.32004094 |
| 28 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.32004094 |
| 29 | Hyperacusis (HP:0010780) | 2.22706726 |
| 30 | Spontaneous hematomas (HP:0007420) | 2.21501701 |
| 31 | Asymmetric septal hypertrophy (HP:0001670) | 2.21460284 |
| 32 | Slow saccadic eye movements (HP:0000514) | 2.19106214 |
| 33 | Inflammation of the large intestine (HP:0002037) | 2.18906398 |
| 34 | Recurrent viral infections (HP:0004429) | 2.17724729 |
| 35 | Annular pancreas (HP:0001734) | 2.14221435 |
| 36 | Hypochromic anemia (HP:0001931) | 2.11086052 |
| 37 | Poikiloderma (HP:0001029) | 2.09310058 |
| 38 | Turricephaly (HP:0000262) | 2.07533862 |
| 39 | Optic neuritis (HP:0100653) | 2.05014668 |
| 40 | Retrobulbar optic neuritis (HP:0100654) | 2.05014668 |
| 41 | Nasal polyposis (HP:0100582) | 2.04708951 |
| 42 | Increased cerebral lipofuscin (HP:0011813) | 2.00978183 |
| 43 | Dislocated radial head (HP:0003083) | 2.00343294 |
| 44 | Emphysema (HP:0002097) | 1.95191771 |
| 45 | Abnormality of the thoracic spine (HP:0100711) | 1.95031061 |
| 46 | Epistaxis (HP:0000421) | 1.94447055 |
| 47 | Cerebral aneurysm (HP:0004944) | 1.93817837 |
| 48 | Abnormality of the nasal mucosa (HP:0000433) | 1.93715883 |
| 49 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.91099428 |
| 50 | Hypertriglyceridemia (HP:0002155) | 1.91067433 |
| 51 | Obstructive sleep apnea (HP:0002870) | 1.90674313 |
| 52 | Long palpebral fissure (HP:0000637) | 1.90196799 |
| 53 | Pustule (HP:0200039) | 1.87734814 |
| 54 | Chest pain (HP:0100749) | 1.84586759 |
| 55 | Long eyelashes (HP:0000527) | 1.83892063 |
| 56 | Vaginal fistula (HP:0004320) | 1.83610883 |
| 57 | Malnutrition (HP:0004395) | 1.81390875 |
| 58 | Thin ribs (HP:0000883) | 1.80778850 |
| 59 | Abnormality of the radial head (HP:0003995) | 1.80562664 |
| 60 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.80142863 |
| 61 | Easy fatigability (HP:0003388) | 1.79608345 |
| 62 | Metaphyseal cupping (HP:0003021) | 1.79413285 |
| 63 | Joint hemorrhage (HP:0005261) | 1.78809293 |
| 64 | Spinal cord lesions (HP:0100561) | 1.78640383 |
| 65 | Syringomyelia (HP:0003396) | 1.78640383 |
| 66 | Hypertensive crisis (HP:0100735) | 1.75015614 |
| 67 | Prolonged bleeding time (HP:0003010) | 1.74727511 |
| 68 | Delayed epiphyseal ossification (HP:0002663) | 1.74576816 |
| 69 | Thoracic kyphosis (HP:0002942) | 1.72539693 |
| 70 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.72391866 |
| 71 | Arterial thrombosis (HP:0004420) | 1.72072054 |
| 72 | Viral hepatitis (HP:0006562) | 1.71947967 |
| 73 | Cheilitis (HP:0100825) | 1.70724999 |
| 74 | Osteomyelitis (HP:0002754) | 1.70211964 |
| 75 | Testicular atrophy (HP:0000029) | 1.69891803 |
| 76 | Widely patent fontanelles and sutures (HP:0004492) | 1.68952942 |
| 77 | Persistence of primary teeth (HP:0006335) | 1.68924956 |
| 78 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.67942640 |
| 79 | Abnormality of the columella (HP:0009929) | 1.67787305 |
| 80 | Vasculitis (HP:0002633) | 1.65293091 |
| 81 | Disproportionate tall stature (HP:0001519) | 1.64909917 |
| 82 | Dysostosis multiplex (HP:0000943) | 1.63986213 |
| 83 | Rectal fistula (HP:0100590) | 1.62422203 |
| 84 | Rectovaginal fistula (HP:0000143) | 1.62422203 |
| 85 | Anteriorly placed anus (HP:0001545) | 1.62169261 |
| 86 | Supernumerary nipples (HP:0002558) | 1.62144331 |
| 87 | Mucopolysacchariduria (HP:0008155) | 1.61983521 |
| 88 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.61983521 |
| 89 | Germ cell neoplasia (HP:0100728) | 1.61913190 |
| 90 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.61617019 |
| 91 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.61617019 |
| 92 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.61617019 |
| 93 | Loss of speech (HP:0002371) | 1.61410500 |
| 94 | Subacute progressive viral hepatitis (HP:0006572) | 1.57682864 |
| 95 | Squamous cell carcinoma (HP:0002860) | 1.57560571 |
| 96 | Abnormality of the costochondral junction (HP:0000919) | 1.56402333 |
| 97 | Myocardial infarction (HP:0001658) | 1.55290391 |
| 98 | Progressive external ophthalmoplegia (HP:0000590) | 1.53238195 |
| 99 | Distal lower limb amyotrophy (HP:0008944) | 1.52297409 |
| 100 | Facial hemangioma (HP:0000329) | 1.52215843 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.98885748 |
| 2 | PRPF4B | 3.23160705 |
| 3 | CDK12 | 3.19832225 |
| 4 | ERN1 | 3.09877506 |
| 5 | SMG1 | 2.75424607 |
| 6 | RIPK4 | 2.60790464 |
| 7 | MAP2K3 | 2.44333722 |
| 8 | ICK | 2.39733917 |
| 9 | MAP4K1 | 2.38171240 |
| 10 | SIK1 | 2.32976786 |
| 11 | BLK | 2.24848027 |
| 12 | EEF2K | 2.06687828 |
| 13 | MAP3K10 | 2.01337314 |
| 14 | SIK2 | 1.90379349 |
| 15 | IRAK3 | 1.86852969 |
| 16 | RIPK1 | 1.67901732 |
| 17 | IRAK4 | 1.64461539 |
| 18 | FGFR4 | 1.50436558 |
| 19 | MAPK15 | 1.50295647 |
| 20 | CSK | 1.44171924 |
| 21 | MARK2 | 1.42404641 |
| 22 | TYK2 | 1.42148654 |
| 23 | ZAP70 | 1.40397629 |
| 24 | BRD4 | 1.39326060 |
| 25 | MAP3K13 | 1.36052494 |
| 26 | MAP3K11 | 1.33683150 |
| 27 | MAP3K3 | 1.26836850 |
| 28 | PDPK1 | 1.25391070 |
| 29 | GRK6 | 1.22920728 |
| 30 | KSR2 | 1.21315440 |
| 31 | PKN2 | 1.21075178 |
| 32 | MAP3K1 | 1.18461827 |
| 33 | TAOK1 | 1.16787095 |
| 34 | CAMK1D | 1.16383465 |
| 35 | PRKD2 | 1.14213921 |
| 36 | MAP3K14 | 1.10991002 |
| 37 | MTOR | 1.09614298 |
| 38 | CDC42BPA | 1.07055152 |
| 39 | TBK1 | 1.06673235 |
| 40 | CDK4 | 1.06378248 |
| 41 | TAOK2 | 1.02529599 |
| 42 | BTK | 1.02318836 |
| 43 | EPHB1 | 0.99585068 |
| 44 | TNK2 | 0.99360633 |
| 45 | TTN | 0.97334338 |
| 46 | DYRK1B | 0.97243954 |
| 47 | CAMK1G | 0.95425769 |
| 48 | TESK2 | 0.95139926 |
| 49 | IRAK2 | 0.94392576 |
| 50 | JAK3 | 0.93656894 |
| 51 | RPS6KA2 | 0.92517208 |
| 52 | RPS6KC1 | 0.91986530 |
| 53 | RPS6KL1 | 0.91986530 |
| 54 | HCK | 0.91518806 |
| 55 | PDK1 | 0.87944673 |
| 56 | DDR2 | 0.86374879 |
| 57 | PTK6 | 0.85712577 |
| 58 | MAPK11 | 0.85511709 |
| 59 | IKBKE | 0.83224388 |
| 60 | WNK1 | 0.79207258 |
| 61 | FES | 0.78071503 |
| 62 | HIPK2 | 0.74941176 |
| 63 | CSF1R | 0.73237745 |
| 64 | RPS6KA6 | 0.72573964 |
| 65 | SIK3 | 0.72568629 |
| 66 | SYK | 0.71572480 |
| 67 | FGR | 0.68797347 |
| 68 | MAP3K7 | 0.67539335 |
| 69 | CDK6 | 0.67034614 |
| 70 | MAPK12 | 0.65897580 |
| 71 | STK38 | 0.62295379 |
| 72 | FGFR3 | 0.61704234 |
| 73 | JAK2 | 0.61475906 |
| 74 | MAP3K8 | 0.58397920 |
| 75 | BMX | 0.57975792 |
| 76 | RET | 0.57167884 |
| 77 | SGK3 | 0.57123968 |
| 78 | CDK7 | 0.56068404 |
| 79 | IKBKB | 0.55336587 |
| 80 | LYN | 0.55323806 |
| 81 | CHUK | 0.54097528 |
| 82 | TYRO3 | 0.53879117 |
| 83 | JAK1 | 0.52850772 |
| 84 | MELK | 0.52483582 |
| 85 | RPS6KA1 | 0.52222939 |
| 86 | MAP2K2 | 0.51489926 |
| 87 | PDGFRA | 0.50656370 |
| 88 | MAPK7 | 0.47004973 |
| 89 | TLK1 | 0.45433534 |
| 90 | PRKD3 | 0.45328570 |
| 91 | MAP3K6 | 0.45050937 |
| 92 | LCK | 0.44541860 |
| 93 | MATK | 0.41666283 |
| 94 | KIT | 0.39669688 |
| 95 | PIM1 | 0.39035235 |
| 96 | MARK3 | 0.36619315 |
| 97 | BRAF | 0.35404596 |
| 98 | RAF1 | 0.35026437 |
| 99 | NEK6 | 0.34221721 |
| 100 | PIM2 | 0.34168715 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.23325614 |
| 2 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.19357894 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.13398794 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.09830890 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.95382167 |
| 6 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.83911253 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 1.81779474 |
| 8 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.81119841 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.78944459 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.69877848 |
| 11 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.63272439 |
| 12 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.61388889 |
| 13 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.59890816 |
| 14 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.56266845 |
| 15 | Influenza A_Homo sapiens_hsa05164 | 1.47293710 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.45365323 |
| 17 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.43713893 |
| 18 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.38656759 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 1.38640237 |
| 20 | Hepatitis B_Homo sapiens_hsa05161 | 1.36804572 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.35862479 |
| 22 | Bladder cancer_Homo sapiens_hsa05219 | 1.35613681 |
| 23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.32496689 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.29143696 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28056617 |
| 26 | Endometrial cancer_Homo sapiens_hsa05213 | 1.27575293 |
| 27 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.26954784 |
| 28 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.26798827 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.25413249 |
| 30 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.19197266 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.18235916 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.17343401 |
| 33 | Hepatitis C_Homo sapiens_hsa05160 | 1.16694225 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.13595972 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.12557019 |
| 36 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.11736124 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10163444 |
| 38 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.10136596 |
| 39 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.10004392 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.07753590 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.07629654 |
| 42 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.07406049 |
| 43 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.06632280 |
| 44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.05006086 |
| 45 | Allograft rejection_Homo sapiens_hsa05330 | 1.04380849 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.03221300 |
| 47 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.02223423 |
| 48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.01471708 |
| 49 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.00492800 |
| 50 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.99487993 |
| 51 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.99456181 |
| 52 | Prostate cancer_Homo sapiens_hsa05215 | 0.98422510 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 0.95340419 |
| 54 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.93717756 |
| 55 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.93705281 |
| 56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.92002225 |
| 57 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.91501826 |
| 58 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91272835 |
| 59 | Insulin resistance_Homo sapiens_hsa04931 | 0.91216272 |
| 60 | Lysosome_Homo sapiens_hsa04142 | 0.91158607 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.90910688 |
| 62 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.90213976 |
| 63 | Endocytosis_Homo sapiens_hsa04144 | 0.89861717 |
| 64 | Colorectal cancer_Homo sapiens_hsa05210 | 0.89523472 |
| 65 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.86949315 |
| 66 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.86787033 |
| 67 | Glioma_Homo sapiens_hsa05214 | 0.86776147 |
| 68 | Thyroid cancer_Homo sapiens_hsa05216 | 0.86463671 |
| 69 | HTLV-I infection_Homo sapiens_hsa05166 | 0.85481678 |
| 70 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.84743611 |
| 71 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.84575292 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.81483103 |
| 73 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.79840312 |
| 74 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.79507855 |
| 75 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.79307208 |
| 76 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.79089830 |
| 77 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.78409152 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77743376 |
| 79 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.77296919 |
| 80 | Platelet activation_Homo sapiens_hsa04611 | 0.76544926 |
| 81 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74888871 |
| 82 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.71807985 |
| 83 | Legionellosis_Homo sapiens_hsa05134 | 0.71129050 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70091658 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.69054453 |
| 86 | Lysine degradation_Homo sapiens_hsa00310 | 0.68738213 |
| 87 | Sulfur relay system_Homo sapiens_hsa04122 | 0.68712042 |
| 88 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.68140442 |
| 89 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66113285 |
| 90 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.66071577 |
| 91 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.63787888 |
| 92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.63604283 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62490515 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60927421 |
| 95 | Salmonella infection_Homo sapiens_hsa05132 | 0.60428061 |
| 96 | Pertussis_Homo sapiens_hsa05133 | 0.59838372 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.58968691 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | 0.58071890 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.57554283 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56157495 |

